FDA vaccine advisers revealed that the United States is expected to approve the use of Pfizer’s coronavirus vaccine next week.
Overseas Network, December 6 – A senior vaccine consultant of the U.S. Food and Drug Administration (FDA) revealed on Saturday (5th) that the country is expected to approve the use of Pfizer’s coronavirus candidate vaccine next week.
According to the Capitol Hill, James Hildreth, a member of the FDA Vaccine Advisory Committee, said in an interview with the US media on the 5th that the agency will vote next Thursday whether to provide emergency use authorization (EUA) for Pfizer vaccines and whether to be the second The distribution of vaccines began on the 11th.
“We’ll spend one day on Thursday reviewing Pfizer’s data and voting after the same day’s review ends.” “If the FDA director decides to issue EUA on voting day, we may see vaccinations starting across the country,” Hildreth said.
Early data show that Pfizer’s coronavirus vaccine is 95% effective, and the United Kingdom is the first country to approve the emergency use of the vaccine. However, Britain rushed across the finish line first, provoking a war of words between Britain, the European Union and the United States.
While boasting, senior British officials did not forget to step on the European Union and the United States. The European Union and the United States question that the United Kingdom is hasty and the regulatory procedures are not rigorous.
